Outlook Therapeutics OTLK
NASDAQ OTLK
$0.59 +0.02 (+3.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Asset Writedowns and Impairment (2018 - 2020)

Updated

Outlook Therapeutics' Asset Writedowns and Impairment was $527,624 in FY2020 (year ended Sep 30, 2020), down 95.3% from $11.3 million in FY2019.

Analysis

Outlook Therapeutics (OTLK) Asset Writedowns and Impairment (2018 - 2020) Analysis & Trends

  • Per Business Quant data, Asset Writedowns and Impairment in earlier fiscal years was $11.3 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Outlook Therapeutics 80.68 Mn 44.93 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 104,296.00
Mar 31, 2020 423,328.00
Sep 30, 2019 8.34 Mn
Jun 30, 2019 50,927.00
Mar 31, 2019 561,735.00
Dec 31, 2018 2.35 Mn
API Access

Outlook Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=OTLK&period=max&api_key=YOUR_API_KEY